Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing
Frank S Ong(Cedars-Sinai Medical Center), Wayne W. Grody(University of California, Los Angeles), Mark O. Goodarzi(Cedars-Sinai Medical Center), Jane Kuo(Cedars-Sinai Medical Center), Jerome I. Rotter(Harbor–UCLA Medical Center), Jay Wang(Baylor College of Medicine), Hana Vakil(University of California, Los Angeles), Kingshuk Das(University of California, Los Angeles), Stephen Lim(Cedars-Sinai Medical Center), Wendell-Lamar B. Blackwell(Cedars-Sinai Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center)
Cited by 96
Related Papers
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k